1
BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)
Condition(s):Hodgkin LymphomaLast Updated:February 26, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Hodgkin LymphomaLast Updated:February 26, 2024Active, not recruiting
Condition(s):Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin LymphomaLast Updated:February 7, 2022Completed
Condition(s):Relapsed or Refractory EBV-and CD30-positive LymphomasLast Updated:November 4, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.